Pinnacle Financial Group, Inc.’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
Other funds holding CADL
ACA
SVCM
Pinnacle Financial Group, Inc.'s CADL Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. opened a new position in Candel Therapeutics (CADL) in Q3 2026: 117,000 shares worth $1.22M. The stake represents 0.12% of the portfolio and ranks #148 among its holdings.
139 funds tracked by Wall St. Rank hold CADL as of Q3 2026.
- Pinnacle Financial Group, Inc. held 117,000 shares of Candel Therapeutics worth $1.22M as of Q3 2026.
- Candel Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
- Candel Therapeutics made up 0.12% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #148 holding.
- 139 funds tracked by Wall St. Rank held Candel Therapeutics as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.